about
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the ful...
Read More
19.16
-0.08
(-0.42%)
121.5K
XNAS Volume
XNAS 12 Nov, 2025 2:43 PM (EST)
Board Meeting
The next board meeting for Septerna Inc. is on 20 Nov 2025 for the purpose of Septerna Inc Third Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Septerna Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..